dbio NEWS
& MEDIA
  • Facebook - Black Circle
  • Twitter - Black Circle
  • YouTube - Black Circle

follow US

FOLLOW US

NEWS

RSS Feed
 

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Pandion Therapeutics Inc. Distributed Bio will use its proprietary SuperHuman antibody library platform to discover therapeutic ready pre-optimized antibodies against multiple Pandion targets. Pandion will have the right to develop and commercialize therapeutic programs resulting from the collaboration. Pandion will also directly license multiple lead antibodies from Distributed Bio and may internalise the SuperHuman platform. "We’re delighted to be working with the most innovative compan

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob Glanville, Co-Founder and Chief Science Officer of Distributed Bio. “From analyzing thousands of human immune systems with our machine learning AbGenesis platform, we have harvested from nature the rules of making exceptional therapeutic

WE'RE HIRING!

We are looking for some awesome new team members!! Send over your information if you're interested!! Looking forward to hearing from you. E-mail us your resume & cover letter info@distributedbio.com OPEN POSITIONS Business Development Facilities Management Marketing Specialist Sales

PRESS

 

Distributed Bio in the news

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio's efforts to 

BUSINESS WIRE | Oct 25, 2018

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio Announces SuperHuman Platform Transfer to Kadmon

BUSINESS WIRE | Feb. 28, 2018

Pfizer, Boehringer sign JLABS resident Distributed Bio’s antibody discovery platform

FIERECE BIOTECH | Jan. 11, 2018

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

BUSINESS WIRE | Jan. 5 2018

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

BUSINESS WIRE | Dec. 12, 2017

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

BUSINESS WIRE | Dec. 11, 2017

VIDEOS

All videos are free to view & download

 

PUBLICATIONS

 

PRESENTATIONS

All presentations are free to view & download

 

SUPERHUMAN 2.0

CARTERRA

PROTEIN ENGINEERING

SUMMIT

IBC TALK 2017

PEGS 2012

THE BETTER BIOLOGIC

PEGS 2013

REPERTOIRE ANALYSIS

& BIOLOGICS OPTIMIZATIONS

NOVEL SEQUENCING TECHNIQUES & COMPUTATIONAL DISCOVERY

CHARACTERIZING HERITABLE VARIATION IN THE ANTIBODY REPERTOIRE

(415) 489-0246

201 Gateway Blvd, Floor 1

 South San Francisco, CA 94080, USA